About Us

Pine Pharmaceuticals is Established

Alfonse Muto and Alfonse J. Muto, Pharm.D. register with the FDA shortly after the passage of Section 503B under the FD&C Act, establishing Pine Pharmaceuticals in a 5,000 sq. ft. facility.

New Therapeutic Offerings

Pine continues its growth within the industry by launching six products addressing new therapeutic areas, expanding its impact on patient care.

Pine Partners with ASCs

Pine releases six new ophthalmology products, enhancing its ability to partner with ambulatory surgery centers.

Additional Custom Compounds

Pine diversifies its catalog with five additional custom compounds, offering physicians new ready-to-use options to address individual patient needs more effectively.

New cGMP-Compliant Facility

Pine unveils a new 25,000 sq. ft. cGMP-compliant facility, doubling its previous facility size and workforce and paving the way for the launch of four new products.

Providing Aid During the Pandemic

Pine aids in the COVID-19 pandemic relief efforts, supplying hand sanitizer nationwide.

Pine Adds 50,000 sq. ft. Expansion

Pine triples in size with a 50,000 sq. ft. expansion, enabling additional manufacturing, quality control, and warehousing capabilities. This growth strengthens its ability to address drug shortages and meet increasing demand.

Strengthening Support for Hospital Systems

Pine expands its presence in the hospital market, introducing nine ready-to-administer IV bags. A new quality control lab is also established, enhancing its in-house testing capabilities.

Continuing Excellence

Today, Pine partners with hospitals, surgery centers, and specialty practices nationwide, distributing millions of units yearly.